Bicycle Therapeutics
BCYC
$21.36
Share price
-3.70%
Change (1 day)
-11.48%
Change (1 year)
Categories
Bicycle Therapeutics (BCYC) - P/B ratio
P/B ratio as of May 2024 : 2.28
According to Bicycle Therapeutics's latest financial reports the company has a price-to-book ratio of 2.28.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Bicycle Therapeutics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.84 | -43.36% |
| 2022-12-31 | 3.25 | -37.59% |
| 2021-12-31 | 5.20 | 31.09% |
| 2020-12-31 | 3.97 | 117.87% |
| 2019-12-31 | 1.82 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | 19.21% | 🇺🇸 USA |